Business News- Cousins Properties (NYSE:CUZ), Perrigo (NYSE:PRGO), Johnson & Johnson (NYSE:JNJ), Plains All American Pipeline (NYSE:PAA) | The Cinema Post
Monday , June 26 2017
Home / Business News / Business News- Cousins Properties (NYSE:CUZ), Perrigo (NYSE:PRGO), Johnson & Johnson (NYSE:JNJ), Plains All American Pipeline (NYSE:PAA)

Business News- Cousins Properties (NYSE:CUZ), Perrigo (NYSE:PRGO), Johnson & Johnson (NYSE:JNJ), Plains All American Pipeline (NYSE:PAA)

Cousins Properties Inc (NYSE:CUZ) (In Eye of Expert, Trend Analysis after Current Fluctuation? Get Her Free Report) reported that it has appointed by Genuine Parts Company to develop a 150,000 square foot corporate headquarters building in Atlanta, Georgia. Construction is slated to begin during the first quarter of 2015 with an expected occupancy in the summer of 2016. Cousins Properties Inc (NYSE:CUZ) saw as a loser stock in last session, fell -0.16% to finished at $12.28 with the overall average volume of 1.46 million shares.

Perrigo Company plc Ordinary Shares (NYSE:PRGO) (Read Report! How PRGO Noticeable Reacts on News Jerk?) reported that the pricing of the registered public offering by Perrigo Finance plc of $1.6B Senior Notes. The notes consist of $500M aggregate principal amount of 3.50% Senior Notes due 2021, $700M aggregate principal amount of 3.90 percent Senior Notes due 2024 and $400 million aggregate principal amount of 4.90% Senior Notes due 2044 Perrigo Company plc Ordinary Shares (NYSE:PRGO) settled at the price of $156.89 with positive change of 1.55% as its highest price in last session was noted at $158.24. On analysts consideration, the mean recommendation of this week is 1.8, [(Strong Buy 1.0 – 5.0 (Sell)] as compare to last week mean recommendation of 1.8, which indicates zero volatility in recommendations.

Janssen Research & Development, a Johnson & Johnson (NYSE:JNJ) (Find Your Indebt Report on JNJ, to be Informed Well) company, reported that it has submitted a New Drug Application for YONDELIS (trabectedin) to the FDA for the treatment of patients by means of advanced soft tissue sarcoma (STS), comprises liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.  Johnson & Johnson (NYSE:JNJ) has its total traded volume during previous session was 9.10 million shares with share price change of -0.91% to settled at $106.88.

Plains All American Pipeline, L.P. (NYSE:PAA) (Watch Expert Views In Detail on PAA Here) released that it aims to provide additional pumps to surge the takeaway capacity of the Cactus Pipeline in response to higher regional production estimates as well as shipper demand. Plains All American Pipeline, L.P. (NYSE:PAA) after opening at $54.30 hit its day high price of $54.47 moreover fell -1.86% to closed at $53.32. The consensus average revenue estimates are $11.70B for latest quarter, at the same time as 8 experts predict $11.83B revenues for the next three months of 2014.

For latest Market Updates Subscribes Here

Facebook Comments